Kinvard Bio has been formed through a licensing agreement with Harvard University. Kineticos is licensing research from the lab of Andy Myers, a professor in Harvard’s Department of Chemistry and ...

Topline clinical data of the confirmatory registrational study GLOW2 expected in 1Q 2026. <li /> GLOW2 study design mirrors GLOW1 study, ...

Topline clinical data of the confirmatory registrational study GLOW2 expected in 1Q 2026. GLOW2 study design mirrors GLOW1 study, which met primary endpoint and ...

Researchers from the Icahn School of Medicine at Mount Sinai in New York have discovered a novel approach to protecting insulin-producing beta cells from the damaging effects of glucolipotoxicity-a ...

See details of the series below and watch the trailer above. PREVIOUS, Feb. 3: We’re getting the first look at Part 2 of Tyler Perry’s Beauty in Black ahead of its March 6 premiere.

The company will publish its Full-Year 2024 financial results on March 26, 2025. On the reporting date, BioVersys will issue a press release at 7:00 AM CET.

Eradivir, a clinical-stage small molecule immunotherapy biotech company, announced it has begun a Phase 2 challenge study with its antiviral therapeutic, EV25. The study will provide safety and ...

A streamlined synthesis of the psychoactive compound ibogaine could open up new opportunities in the treatment of drug ...

In this edition of “Rising High,” The Fly conducted an exclusive interview with Jared Stanley, Chief Executive Officer, and Joel Stanley, ...

Enliven Therapeutics increased its research and development spending in the fourth quarter of fiscal 2024 as several drug ...

From landmark indies to star-studded blockbusters, Steven Soderbergh has restlessly forged an eclectic body of work.